Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, July 15, 2022
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
Dan Brennan Maintained (TXG) at Buy with Decreased Target to $50 on, Jul 15th, 2022
Dan Brennan of Cowen & Co., Maintained "10x Genomics, Inc." (TXG) at Buy with Decreased Target from $90 to $50 on, Jul 15th, 2022.
Dan has made no other calls on TXG in the last 4 months.
There are 3 other peers that have a rating on TXG. Out of the 3 peers that are also analyzing TXG, 1 agrees with Dan's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Amit Hazan of "Goldman Sachs" Maintained at Hold with Decreased Target to $60 on, Thursday, July 14th, 2022
These are the ratings of the 2 analyists that currently disagree with Dan
- Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $100 on, Friday, May 6th, 2022
- Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Decreased Target to $100 on, Thursday, May 5th, 2022
